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A Novel Modulator of the Th1 Cytokine Response
induction of IFNg in mice deficient in IL-18 (IL-182/2
mice) in response to endotoxin is markedly reduced,
despite normal production of IL-12 (Takeda et al., 1998).
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Natural killer (NK) cells from these IL-182/2 mice also*Department of Molecular Genetics
exhibit an impaired cytotoxic response in vitro.Weizmann Institute of Science
The IL-18 receptor consists of at least two compo-Rehovot 76100
nents, cooperating in ligand binding. High- and low-Israel
affinity binding sites for IL-18 were found in murine²Division of Infectious Diseases
IL-12-stimulated T cells (Yoshimoto et al., 1998), sug-University of Colorado Health Sciences Center
gesting a multiple chain receptor complex. A ligand-Denver, Colorado 80262
binding component of this receptor complex has been
isolated from membrane proteins by affinity purifica-
tion with a neutralizing monoclonal antibody directedSummary
against the IL-18 receptor. The sequence of this receptor
matched that of the previously identified IL-1 receptorAn interleukin-18 binding protein (IL-18BP) was puri-
related protein (IL-1Rrp; Torigoe et al., 1997). A second
fied from urine by chromatography on IL-18 beads,
receptor subunit, termed accessory protein-like (AcPL),
sequenced, cloned, and expressed in COS7 cells. IL- essential for signaling, was recently cloned (Born et al.,
18BP abolished IL-18 induction of interferon-g (IFNg), 1998). Both receptor subunits belong to the IL-1 recep-
IL-8, and activation of NF-kB in vitro. Administration of tor family (Parnet et al., 1996).
IL-18BP to mice abrogated circulating IFNg following IL-18 shares with IL-1 and TNF family members some
LPS. Thus, IL-18BP functions as an inhibitor of the of their signaling mechanisms. Following exposure to
early Th1 cytokine response. IL-18BP is constitutively IL-18, IL-1Rrp recruits the IL-1 receptor activating kinase
expressed in the spleen, belongs to the immunoglobu- (IRAK), which in turn associates with the downstream
lin superfamily, and has limited homology to the IL-1 signaling molecule TRAF6 (Croston et al., 1995; Rob-
type II receptor. Its gene was localized on human chro- inson et al., 1997; Kojima et al., 1998). The latter was
mosome 11q13, and no exon coding for a transmem- found to associate with the NF-kB-inducing kinase (NIK;
brane domain was found in an 8.3 kb genomic se- Malinin et al., 1997), which activates a signaling cascade
quence. Several Poxviruses encode putative proteins involving two IkB kinases, IKKa and IKKb. IkB, the spe-
highly homologous to IL-18BP, suggesting that viral cific substrate of IKKs, is constitutively associated with
products may attenuate IL-18 and interfere with the NF-kB. Upon phosphorylation of IkBa by IKK, cyto-
cytotoxic T cell response. plasmic NF-kB is released and translocates to the nu-
cleus, where its dimeric forms act as transcription fac-
tors (DiDonato et al., 1997; Regnier et al., 1997).Introduction
IL-1Rrp exhibits a rather low affinity (Kd of 25±45 nM)
for IL-18. Previously, it was demonstrated that solubleThe cytokine interleukin (IL)-18, initially described as
receptors corresponding to ligand-binding domains ofan interferon-g (IFNg)-inducing factor (Nakamura et al.,
cytokine receptors may be conveniently isolated from1989), is an early signal in the development of T-lympho-
urine and then used for cloning of the cell-surface recep-cyte helper type 1 (Th1) responses. IL-18 acts together
tor (Engelmann et al., 1989, 1990; Novick et al., 1989,with IL-12, IL-2, antigens, mitogens, and possibly IFNa
1994). In each case, the sequence of the isolated soluble(Sareneva et al., 1998) to induce the production of IFNg
receptor was identical to the extracellular ligand-binding(Okamura et al., 1998). IL-18 also enhances the produc-
domain of a corresponding cell surface receptor.tion of GM-CSF and IL-2, potentiates anti-CD3-induced
Here, we present the isolation of an IL-18 bindingT cell proliferation, and increases Fas-mediated killing
protein (IL-18BP) from human urine and cloning of itsof natural killer cells (Micallef et al., 1996; Tsutsui et al.,
human and mouse cDNA and the human gene. Unlike1996). The obligatory role for IL-18 in IFNg production
previously isolated urinary proteins, IL-18BP is not awas first demonstrated by using passive immunization
variant of a cell-surface receptor. The urinary IL-18BP,with antibodies to murine (mu) IL-18 (Okamura et al.,
as well as IL-18BP expressed in COS7 cells, specifically1995). The secondary structure of IL-18 associates it
bound IL-18 and neutralized its biological activity inwith the IL-1 family of cytokines (Bazan et al., 1996),
vitro. Furthermore, recombinant IL-18BP inhibited lipo-
and similarly to IL-1, mature IL-18 is produced from its
polysaccharide (LPS) induction of IFNg in mice. IL-18BP
precursor by the IL-1b converting enzyme (ICE, cas- belongs to a novel family of secreted proteins, which
pase-1). Indeed, the lack of IFNg production following include several Poxvirus-encoded proteins, suggesting
endotoxin in mice deficient in caspase-1 was attributed that the latter may also act as inhibitors of IL-18 activity.
to absence of mature IL-18 in these mice (Ghayur et al.,
1997; Gu et al., 1997; Fantuzzi et al., 1998). Similarly, Results
Isolation of an IL-18BP from Human Urine³ To whom correspondence should be addressed (e-mail: lvrub@
In an effort to isolate a soluble IL-18 receptor, we passedweizmann.weizmann.ac.il).
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Figure 1. Affinity Purification of IL-18BP and
Its Cross-Linking with IL-18
(A) Crude urinary proteins from the affinity
purification process were analyzed by SDS-
PAGE (10% acrylamide, nonreducing condi-
tions) and stained with silver. Lane 1, crude
urinary proteins (1.5 mg); lanes 2±9 depict 50
ml samples of progressively eluted fractions.
The yellow protein band indicated by an
arrow is IL-18BP. Molecular weight markers
are indicated on the right side.
(B) Aliquots of fractions from the affinity puri-
fication process cross-linked to 125I-IL-18
were analyzed by SDS-PAGE (7.5% acryl-
amide) under reducing conditions. Lane 1, a
fraction containing unbound crude urinary
proteins. Lane 2, a partially purified IL-18BP
(elution fraction 2, Figure 1A, lane 3). Lane 3,
a purified IL-18BP (elution fraction 3, Figure
1A, lane 4). The arrow indicates the cross-
linked 58 kDa product. The lower band is un-
bound 125I-IL-18.
of normal human urine on an IL-18-agarose column. by Con A, even at high concentrations of the binding
protein (Figure 2B). This observation demonstrated thatFollowing washing, bound proteins were eluted at a low
IL-18BP was a specific inhibitor of IL-18 bioactivitypH. As shown in Figure 1A, SDS-PAGE and silver stain-
rather than a nonspecific inhibitor of IFNg production.ing revealed an z40 kDa IL-18BP in the eluted fractions,
IL-18BP also inhibited the activity of huIL-18 in humanexhibiting a distinct yellow color. Upon SDS-PAGE of
cells. Induction of IFNg in KG-1 cells by a combinationan N-glycanase-treated IL-18BP, the z40 kDa band dis-
of IL-18 and TNFa was inhibited by the urinary IL-18BPappeared and a 20 kDa band was observed, suggesting
(Figure 2C). Similarly, induction of IFNg in PBMC by athat the z40 kDa IL-18BP is highly glycosylated (data
combination of IL-18 and IL-12 (Micallef et al., 1996) wasnot shown).
inhibited by the urinary IL-18BP (data not shown).To determine the specificity of IL-18 binding to IL-
The above data demonstrate that urinary IL-18BP in-18BP, aliquots of the z40 kDa IL-18 from the affinity
hibits human as well as muIL-18 activity. The concentra-column were cross-linked with 125I-IL-18 and the re-
tion of IL-18BP that abolished IL-18 activity was compa-sulting products were assessed by SDS-PAGE and auto-
rable to that of IL-18 itself, suggesting a high-affinityradiography. As shown in Figure 1B, a 58 kDa cross-
interaction between these two proteins. Thus, IL-18BPlinked product, corresponding in size to a 1:1 complex
appears to act as a soluble decoy receptor.of the 18±19 kDa IL-18 plus the z40 kDa IL-18BP, was
observed (Figure 1B, lanes 2 and 3). Cross-linking of IL-
Protein Sequencing of the Urinary IL-18BP18 with a wash fraction of the affinity column, consisting
Initial attempts to determine the N-terminal amino acidof urinary proteins not binding to the IL-18 affinity col-
sequence of a PVDF-blotted z40 kDa urinary IL-18BPumn, did not result in any cross-linked product, thereby
band from nonreducing SDS-PAGE yielded a mixed se-demonstrating that the z40 kDa IL-18BP binds IL-18 in
quence of two polypeptides, one corresponding to aa specific manner (Figure 1B, lane 1).
fragment of human defensin and another one starting
with amino acids Thr-Pro-Val. To obtain a single and
Urinary IL-18BP Inhibits the IFNg-Inducing
longer protein sequence, a reduced and alkylated sam-
Activity of IL-18 ple of the affinity-purified IL-18BP was subjected to pro-
IL-18 induces IFNg when added together with low con- tein microsequencing and treated with o-phtalaldehyde
centration of LPS, IL-12, or TNFa. The activity of IL- (OPA) after the first sequencing cycle. OPA blocks all
18BP was tested in murine splenocytes, in the human N-terminal amino acids except that of proline. Indeed,
KG-1 cell line, and in human peripheral blood mononu- using OPA, a single sequence of 40 amino acids resi-
clear cells (PBMC). As shown in Figure 2A, IL-18BP dues was obtained (Figure 3A, dot-underlined section).
blocked the activity of human (hu)-IL-18 in murine splen- This sequence was not found in GenBank; however, a
ocytes in a dose-dependent manner. The activity of re- search in the human cDNA database of The Institute of
combinant murine (mu)-IL-18 was similarly inhibited by Genomic Research (TIGR) resulted in an almost perfect
the huIL-18BP. In contrast, as a control, soluble inter- match with the cDNA clone THC123801, derived from
feron-a/b receptor (sIFNAR2; Novick et al., 1994) had a human Jurkat T cell library and coding for a protein
no effect. High concentrations of LPS (10 mg/ml) induce of unknown function.
endogenous IL-18 in murine splenocytes, as determined
by production of IFNg. Indeed, the urinary IL-18BP inhib- Cloning of the Human and Mouse IL-18BP
ited the production of IFNg by high dose LPS (Figure cDNA and Their Homology with a Family
2B). Concanavalin A (Con A) activates T cells to produce of Putative Poxvirus Proteins
IFNg in the absence of IL-18 (Fantuzzi et al., 1998). As The TIGR cDNA sequence appeared to be incomplete
and had several mismatches when compared with the 40expected, IL-18BP did not inhibit the induction of IFNg
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Figure 2. Inhibition of IL-18-Induced Produc-
tion of IFNg by IL-18BP
(A) Mouse splenocytes were stimulated with
the indicated combinations of LPS and huIL-
18 (black bars), added either in RPMI or after
premixing with urinary IL-18BP in RPMI. Simi-
larly, mouse splenocytes were incubated with
LPS and muIL-18 (white bars), premixed with
increasing concentrations of huIL-18BP.
(B) Mouse splenocytes were incubated with
LPS (10 mg/ml, black circles, to induce en-
dogenous IL-18) and increasing concen-
trations of huIL-18BP. Alternatively, mouse
splenocytes were incubated with Con A (1
mg/ml, white circles) and increasing concen-
trations of huIL-18BP.
(C) Human KG-1 cells were stimulated with
TNFa (20 ng/ml) and huIL-18, premixed with
increasing concentrations of urinary IL-18BP.
amino acid sequence of the urinary IL-18BP. Therefore, murine cDNA sequence. Screening of a mouse spleen
cDNA library with this probe yielded 54 independentseveral cDNA libraries were screened in order to identify
a complete IL-18BP cDNA and possible splice variants. cDNA clones. A group of 15 independent cDNA clones
of 2.6±4 kb (designated muIL-18BPc, accession numberA probe for screening cDNA libraries was prepared by
reverse-transcription-polymerase chain reaction (RT- AF110802) coded for a soluble, secreted protein having
a signal peptide of 26 amino acid residues and a maturePCR) of Jurkat cell RNA with primers from the TIGR
sequence. Four human cDNA libraries, derived from Jur- IL-18BPc of 166 amino acid residues. The open reading
frame of the murine IL-18BPc exhibited 66.7% identitykat cells, peripheral blood monocytes, human PBMC,
and from human spleen were screened. Altogether, with huIL-18BPc at the protein level (Figure 3B). Another
splice variant, designated muIL-18BPd (accession num-we have obtained and characterized 106 independent
cDNA clones, corresponding to three IL-18BP splice ber AF110803), also coded for a soluble protein. No
cDNA coding for a TM IL-18BP was identified in thevariants. All splice variants coded for putative soluble
secreted proteins. The most abundant one, designated human and mouse cDNA libraries.
Homology searches of IL-18BP did not reveal an obvi-IL-18BPa (accession number AF110799), had an open
reading frame of 192 codons. It coded for a signal pep- ous similarity at the primary structure to any cytokine
receptor or to any other known eukaryotic protein. Notide of 28 amino acid residues followed by a mature
putative IL-18BPa, whose first 40 residues matched per- significant homology was found between IL-18BP and
IL-1Rrp. Also, the hydropathy profile of the IL-18BP vari-fectly with the N-terminal protein sequence of the urinary
IL-18BP (Figure 3A). The amino acid sequences around ants did not match that of any known cytokine receptor
(data not shown). Yet, the Ig domain of IL-18BP is homol-cysteines 83 and 148 and tryptophan 98 suggested that
this polypeptide belongs to the immunoglobulin (Ig) su- ogous to the third Ig domain of the decoy receptor IL-
1R type II. Furthermore, IL-18BP was significantly ho-per-family (Williams and Barclay, 1988). Interestingly,
each of the four Gln residues within mature IL-18BPa mologous to a family of putative proteins encoded by
several Poxviruses. These viral proteins also belong towas a potential N-glycosylation site. The two other
splice variants of IL-18BP were significantly less abun- the Ig superfamily. Each has a signal peptide and there-
fore appears to be secreted. Two genes of these pro-dant (see below).
Database searching of murine cDNA libraries for teins were found in the genome of Molluscum contagio-
sum virus (MCV) subtype 1, whereas others were foundhomologs of human IL-18BP revealed a partially se-
quenced (447 bp) cDNA clone of unknown function in Swinepox, Cowpox, Variola, and Ectromelia viruses.
The highest homology (47% identity in a sequence of(GenBank accession number AA498857). Its partial open
reading frame of 74 codons was 65.7% identical at the 82 amino acid residues) was obtained with the putative
protein encoded by open reading frame (ORF) 54L ofamino acid level with the huIL-18BP. This level of homol-
ogy suggested that clone AA498857 is the cDNA of the MCV genome. Each of these viral proteins showed
homology to the Ig domain (codons 82±163) of the huIL-muIL-18BP. A probe was then prepared by RT-PCR of
RNA from mouse spleen with primers from the partial 18BPa (Figure 3B).
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Figure 3. The Sequence of huIL-18BPa cDNA
and Protein
(A) Nucleotide and amino acid sequence of
huIL-18BPa. The signal peptide is underlined
and the region corresponding to the N-termi-
nal protein sequence of the urinary IL-18BP
is indicated by a dotted line. Putative N-gly-
cosylation sites are indicated by asterisks
and the polyadenylation signal is underlined.
(B) Homology among IL-18BP family mem-
bers. The immunoglobulin domains of human
and muIL-18BP were compared with those
of putative viral proteins whose GenPept file
number is shown on the left. Regions of high
homology are boxed and highly conserved
residues are shown in bold. The Variola virus
protein VVU18340_6 is also expressed in cow-
pox virus (GenPept file CV41KBPL_14) and in
Ectromelia virus (GenPept file U01161_3).
IL-18BP Expressed in COS7 Cells same molecular mass and were immunologically cross-
reactive as determined by immunoblotting with antibod-Is Biologically Active
A vector coding for human IL-18BPa with a His6 tag at ies to the urinary IL-18BP (Figure 4A). Therefore, IL-
18BPa corresponds structurally to the urinary IL-18BP.its C terminus was constructed and used for transient
expression of IL-18BPa in monkey COS7 cells. The The recombinant IL-18BPa was then tested for its
ability to inhibit the biological activity of IL-18 in vitro.structure and biological activity of purified recombinant
IL-18BPa was compared with that of the urinary IL-18BP. IL-18 activates NF-kB in human KG-1 cells as deter-
mined by electrophoretic mobility shift assay with cellThe recombinant protein gave a single z40 kDa band
upon SDS-PAGE and silver staining under reducing and extracts and a radiolabeled oligonucleotide of the NF-
kB consensus sequence. IL-18 induced the formationnonreducing conditions (data not shown). Protein se-
quence analysis of recombinant IL-18BPa revealed the of the p50 NF-kB homodimer. We found that urinary
and recombinant IL-18BP blocked the IL-18-inducedsame N-terminal sequence as that of the urinary IL-
18BP, indicating that the latter was not degraded at its formation of the p50 NF-kB homodimer (Figure 4B). In-
duction of the p65/p50 NF-kB heterodimer by IL-18 wasN terminus. Recombinant and urinary IL-18BP had the
A Circulating IL-18 Binding Protein
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Figure 4. Recombinant IL-18BPa-His6 Is Im-
munologically Cross-Reactive with Urinary
IL-18BP and Inhibits Human and Murine IL-
18 Activity In Vitro
(A) IL-18BP was subjected to SDS-PAGE
under nonreducing conditions and immuno-
blotting with a rabbit antiserum to urinary
IL-18BP. Lanes 1 and 7, molecular mass
markers; lane 2, urinary IL-18BP; lanes 3±6,
recombinant IL-18BPa-His6, produced in COS7
cells and successively eluted in four fractions
from a metal chelate column.
(B) KG-1 cells were stimulated with huIL-18,
added either in RPMI or after premixing with
IL-18BP in RPMI. Cell extracts were mixed
with a labeled ds DNA corresponding to the
NF-kB binding element and subjected to elec-
trophoretic mobility shift assay. The lanes
are: 1, control; 2, IL-18; 3, IL-18 preincubated
with urinary IL-18BP; and 4, IL-18 preincu-
bated with IL-18BPa-His6.
(C) Mouse splenocytes were stimulated with
the indicated combinations of LPS and huIL-
18 (black circles), premixed with the indicated
concentrations of IL-18BPa-His6. Similarly,
mouse splenocytes were incubated with LPS
and muIL-18 (white circles) premixed with in-
creasing concentrations of human IL-18BPa-
His6. IFNg level was determined in the cul-
tures.
(D) Human KG-1 cells were stimulated with
TNFa (20 ng/ml) and huIL-18 (10 ng/ml), premixed with the indicated concentrations of IL-18BPa-His6. The level of huIFNg in the culture was
then determined.
(E) Human PBMC were stimulated with IL-12 (10 ng/ml) and huIL-18 (25 ng/ml), pre-mixed with the indicated concentrations of IL-18BPa-His6.
The level of IL-8 in the cultures was then determined. Control and the dashed line represent basal IL-8 level in noninduced cultures of PBMC
(n 5 3).
seen only upon a longer exposure (data not shown) and Administration of Recombinant IL-18BP Inhibits
LPS-Induced IFNg In Vivowas also inhibited by IL-18BP.
To test the effects of IL-18BP in vivo, mice were injectedRecombinant IL-18BPa inhibited in a dose-dependent
intraperitoneally with LPS, LPS plus recombinant IL-manner the IFNg-inducing activity of human and murine
18BP, or IL-18BP alone. Sera, splenocytes, as well asIL-18 in murine splenocytes. Thus, at an z10-fold molar
mRNA from spleen cells were obtained 6 hr post injec-excess, IL-18BP abolished the activity of human and
tion. RNA blot analysis revealed that IFNg mRNA wasmuIL-18 (Figure 4C). Similar results were obtained when
nondetectable in splenocytes of mice injected with LPShuman KG-1 cells were induced with huIL-18 (Figure 4D).
plus IL-18BP compared to LPS only (Figure 5A). ELISAInduction of IFNg by IL-18 in PBMC was also inhibited by
of serum IFNg revealed that IL-18BP inhibited LPS-IL-18BP (data not shown). Similarly, induction of the
induced circulating IFNg by .90% (P , 0.001, Figureproinflammatory chemokine IL-8 by huIL-18 in PBMC
5B). IFNg was not detected in sera of mice injected withwas inhibited by recombinant IL-18BPa in a dose-
IL-18BP alone. We also observed a significant reductiondependent manner, bringing it to basal levels (Figure 4E).
in spontaneous IFNg production in splenocyte culturesBecause IL-18 and IL-1 are structurally related (Bazan et
from mice injected with LPS plus IL-18BP compared toal., 1996), we tested the ability of IL-18BP to interact
LPS only (0.047 6 0.03 ng/ml, n 5 3 versus 0.57 6 0.17
with IL-1. IL-1b (10 ng/ml) was preincubated either with
ng/ml, n 5 3, respectively, P , 0.05). In contrast, IL-1b
control medium or with medium containing IL-18BP (250 mRNA was unaffected in mice injected with LPS plus
ng/ml). The mixtures were added to cultures of PBMC IL-18BP compared to LPS only (data not shown). Given
and the level of IL-1-induced IL-8 was determined after the multiple cytokine cascade triggered by LPS in vivo,
48 hr. We found that IL-18BP did not inhibit the activity coadministration of IL-18BP selectively and effectively
of IL-1b (n 5 3; data not shown). inhibits IFNg gene expression, synthesis, and release
The results of the bioassays as well as the NF-kB in vivo.
mobility shift demonstrate that inhibition of IL-18 activity
is an intrinsic property of the cloned human IL-18BP Genomic Organization and Chromosomal
and not that of any accompanying impurities in urinary Localization of the IL-18BP Gene
IL-18BP, such as the coeluting fragment of defensin. To study the possible existence of membrane-associ-
ated forms of IL-18BP, we screened a human genomicFurthermore, IL-18BP is a specific inhibitor of IL-18.
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2956) gave rise to at least three splice variants. Each of
them shared a common ATG translation start site and
coded for the same signal peptide of 28 amino acid
residues. All variants coded for a soluble mature protein,
varying somewhat in its size and in its C-terminal se-
quence. The abundant IL-18BPa cDNA (96 independent
clones) consisted of five exons, coding for a mature
protein of 164 amino acid residues. A shorter rare splice
variant (1 kb, designated IL-18BPb, accession number
AF110800), represented by three independent cDNA
clones, coded for a mature protein of 85 amino acid
residues. A third variant, IL-18BPc (accession number
AF110801), represented by seven independent cDNA
clones, was significantly longer (a 7 kb sequence was
Figure 5. Recombinant IL-18BP Inhibits LPS-Induced IFNg In Vivo constructed from two partial cDNA clones), but also
(A) Four groups of three C57Bl6 mice were injected with PBS (lane coded for a soluble protein of 169 amino acid residues.
1), LPS (100 mg/mouse, lane 2), LPS plus recombinant huIL-18BPa The 59 untranslated region (UTR) of IL-18BPc was longer
(lane 3), or IL-18BPa alone (lane 4). After 6 hr, total RNA was isolated
than that of the other two splice variants, suggestingfrom mouse splenocytes and aliquots (7 mg) were blotted with a
that its expression may be differently regulated.cDNA probe corresponding to muIFNg. An actin probe was used
The IL-18BP locus contains an additional gene, cod-for normalization. BP denotes IL-18BPa.
(B) IFNg levels in sera of the various groups of mice (see A), 6 hr ing for the nuclear mitotic apparatus protein 1 (NuMA1),
post injection. Inset: two rows of the microtiter plate showing the positioned at the minus strand (accession number
amount of IFNg as detected in the ELISA wells, containing sera of AF110460). This finding localizes the IL-18BP gene to
3 mice, each one nondiluted and 2-fold diluted. Upper row (-): IFNg
human chromosome 11q13 (Sparks et al., 1993).from mice injected with LPS alone. Lower row (1): IFNg from mice
injected with LPS plus IL-18BP.
IL-18BP Is Expressed Constitutively Mainly
in the Spleen
RNA blot analysis of IL-18BP showed a major 1.8 kblibrary with a probe corresponding to full-length IL-
18BPa cDNA and identified five genomic clones. These transcript in resting human spleen cells. Other tissues,
including thymus and resting PBMC, revealed the sameclones were subcloned and then subjected to DNA se-
quencing. Altogether, an 8.3 kb sequence was assem- transcript but at a lower intensity. This transcript corre-
sponded in size and abundance to the huIL-18BPabled (accession number AF110798; Figure 6). No exon,
or combination of two adjacent exons, coding for a TM cDNA clone. Longer transcripts were seen as well, but
their intensities were weaker compared with the majordomain was identified within any one of the three reading
frames of the 8.3 kb sequence. 1.8 kb band found in the spleen (Figure 7A). One of the
minor transcripts was $ 8 kb. Its size and relatively lowExon skipping (in genomic nucleotides 2373±2956)
and in-exon splicing (in genomic nucleotides 2724± abundance corresponded to the cloned IL-18BPc. RNA
Figure 6. Exon-Intron Organization of the huIL-18BP Gene
The sequence of 5 huIL-18BP genomic clones (8.3 kb) is aligned with that of the three IL-18BP cDNA clones. Exons are striped and exon
usage is shown in the three splice variants. Translation start sites (ATG), stop codons, polyadenylation signals (PAS), and the position of the
NuMA1 gene on the minus strand are indicated.
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inflammatory cell infiltrates. Since IL-18 induces the
chemokine IL-8 (Puren et al., 1998), inhibition of IL-18
by an MCV-encoded protein may attenuate the inflam-
matory antiviral Th1 response.
At high molar ratios, some soluble receptors, e.g.,
IL-1, IL-4, TNFa, and IFNa /b, inhibit their corresponding
cytokines (Engelmann et al., 1989, 1990; Mosley et al.,
1989; Novick et al., 1994; Sims et al., 1994) and have
been used as immunosuppressors in patients (Moreland
et al., 1997). However, at low concentrations, these solu-
ble receptors may function as stabilizers of cytokines
and enhance their activity, as was reported for IL-4 and
TNFa (Mosley et al., 1989; Aderka et al., 1992). IL-18BP
is highly effective as an inhibitor of IL-18 in vitro, and
when added at lower concentrations, enhancement of
IL-18 activity was not observed. Therefore, IL-18BP
probably functions in vivo as an inhibitor rather than a
Figure 7. Expression of IL-18BP mRNA in Human Tissues and stabilizer of IL-18.
Mouse Spleen A close association of IL-18 expression with autoim-
(A) Human MTN blot II, containing equal amounts of poly(A)1 RNA mune responses was reported in the pancreatic islets
from the indicated tissues, was hybridized with a probe correspond- of nonobese diabetic (NOD) mice. IL-18 mRNA was ob-
ing to the cDNA clone of huIL-18BPa. A major 1.8 kb band (indicated
served during the spontaneous development of autoim-by an arrow) was obtained in the spleen and to a lesser extent in
mune insulitis and diabetes, preceding the rise in IFNgother tissues. A weaker $8 kb band, corresponding in size to the
mRNA and subsequent diabetes (Rothe et al., 1997a,huIL-18BPc cDNA clone, was seen as well.
(B) Poly(A)1 RNA from mouse splenocytes was subjected to RNA 1997b). Endogenous IL-18 also appears to account for
blot analysis with a probe corresponding to muIL-18BPc cDNA. A IFNg production in P. acnes and LPS-mediated lethality
major 1.9 kb band and a minor 5.1 kb band were observed. (Okamura et al., 1995). Therefore, IL-18BP may be bene-
ficial as an inhibitor of various Th1-mediated diseases.
blot analysis of resting mouse splenocytes with a muIL- It is also possible that circulating IL-18BP serves to
18BP cDNA probe revealed a major band of 1.9 kb and inhibit basal levels of IL-18. Unlike the precursors of
a minor band of 5.1 kb (Figure 7B). The cloned muIL- IL-1b or TNFa, that of IL-18 is constitutively expressed
18BPc cDNA probably corresponded in size to the 5.1 in the spleens of normal mice and in freshly obtained
kb transcript. peripheral blood monocytes from healthy humans (Puren
et al., 1998). Therefore, it is likely that the net balance
Discussion of the relative levels of IL-18 and IL-18BP affects immune
responses such as the cytotoxic T cell response to viral
In this study, we describe the isolation and cloning of diseases.
a novel secreted protein, IL-18BP, which binds IL-18 Our studies have shown that human and mouse IL-
and blocks its biological activity. IL-18 is an early signal 18BP is expressed as a soluble protein, lacking a TM
leading to Th1 cytokine responses that are essential for domain. Furthermore, none of the IL-18BP splice vari-
the cytotoxic T cell response. Therefore, IL-18BP may ants that we have identified coded for a protein that has
modulate one of the earliest phases of the Th1 immune the signature of a GPI-anchor at its C terminus (Moran
response. The dramatic (.90%) attenuation of IFNg pro- and Caras, 1991; Moran et al., 1991). In addition, an
duction in mice given recombinant IL-18BP demon- antibody generated against the urinary IL-18BP did not
strated in our study was also observed in mice with the block the biological activity of IL-18 in human PBMC
IL-18-gene disruption after LPS (Takeda et al., 1998). and in KG-1 cells (data not shown). Therefore, IL-18BP
Splenic mRNA level of IL-1b was unaffected by IL-18BP appears to exist only as a soluble circulating protein.
administration, demonstrating the specificity of IL-18BP Since IL-18 is expressed as a leaderless precursor, it is
as a suppressor of IFNg production in vivo. The inability possible that an IL-18 precursor is also inserted into the
of IL-BP to inhibit IL-1b, a structurally related homolog cell membrane of activated macrophages as a biologi-
of IL-18, demonstrates the high specificity of the interac- cally active ªmembrane cytokineº similar to IL-1a (Bailly
tion between IL-18 and IL-18BP. et al., 1990). IL-18BP may block such a cytokine.
IL-18BP is a member of a novel family of soluble pro- The families of the IL-1 and IL-18 receptors are re-
teins, which also includes several Poxvirus-encoded pu- markably similar, not only in structure but also in func-
tative proteins. Poxviruses encode decoy receptors of tion. Type I IL-1 receptor (IL-1R1) and IL-1Rrp are the
many cytokines and these receptors are instrumental in major ligand-binding subunits of IL-1 and IL-18, respec-
viral evasion of immune responses, as demonstrated tively. The IL-1 receptor accessory protein (IL-1RAcP)
by reduced virulence following their deletion (Spriggs, and the recently cloned AcPL function as accessory
1996; Ploegh, 1998). The putative protein encoded by subunits of IL-1R and IL-18R, respectively. Thus, IL-
ORF 54L of the MCV genome is the one most similar 1Rrp and AcPL may now be termed IL-18Ra and IL-
to IL-18BP (Figure 3B). A remarkable feature of MCV 18Rb, respectively. IL-18BP is a soluble decoy receptor,
infection is that it produces small skin lesions, con- structurally and functionally similar to the membrane-
associated IL-1 receptor type II (IL1R2). It is possibletaining a large number of virus particles but lacking
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Human KG-1 cellsthat IL-18BP evolved from a primordial cell-surface pro-
Cells in RPMI-10 (250 ml, 1.2 3 106/ml) were stimulated (24 hr, 378C)tein that lost its membrane-anchoring domain. IL-18BP,
with TNFa (20 ng/ml) together with either huIL-18 (10 ng/ml) orosteoprotegerin, and the recently cloned cytokine-like
IL-18 premixed with IL-18BP. Clarified supernatants of 33 frozen
factor-1 belong to a group of receptor-like proteins that cultures were assayed for huIFNg by ELISA with monoclonal anti-
exist only in a soluble form (Anderson et al., 1997; Simo- bodies Nos. 3.3 and biotin-labeled-166.5, (Novick et al., 1983; Koni-
shi et al., 1997).net et al., 1997; Elson et al., 1998; Yasuda et al., 1998).
Human PBMCIn conclusion, we have identified a constitutively ex-
PBMC were isolated by centrifugation of heparinized blood overpressed circulating inhibitor of IL-18 that is a member
Ficoll-Hypaque gradients and washed with pyrogen-free saline.of a novel family of soluble receptors. Because IL-18 is
Cells (5 3 106 cells/ml) in RPMI containing 1% heat-inactivated
an early stimulant of Th1 cells, IL-18BP probably plays human AB serum were stimulated (48 hr, 378C) as above. Clarified
an important role in regulation of the immune response. supernatants of 33 frozen cultures were assayed for IFNg and IL-8
by an electro-chemiluminisence assay (Igen, Inc., Gaithersburg, MD;
Puren et al., 1998).Experimental Procedures
Protein Sequence AnalysisCells and Reagents
Protein bands blotted onto a PVDF membrane were subjected toKG-1 (CCL 246), COS7 (CRL 1651), and Jurkat (CRL 8163) cells were
protein microsequencing (Model 491 HT-Procise, Applied Biosys-from the American Type Culture Collection. Recombinant huIL-18
tems, Foster City, CA) as described (Matsudaira, 1987). Proteins inwas from Peprotech Inc. (Rocky Hill, NJ), Vertex Pharmaceuticals
solution were sequenced following reduction (2 hr, 100 mM DTT, 6(Cambridge, MA), and R&D Systems (Minneapolis, MN). Recombi-
M guanidine HCl [pH 8]), and alkylation by 4-vinyl pyridine (2 hr,nant huIL-12, huTNFa, and muIL-18 were also from Peprotech. HuIL-
150 mM). N-terminal amino acid residues other than proline were18 (7 3 106 cpm/mg) was radiolabeled by the Bolton and Hunter's
blocked with o-phtalaldehyde in the reaction chamber of the proteinreagent (NEN Life Science products, Boston, MA), according to
sequencer as described (Brauer et al., 1983).the manufacturer's procedure. Crude urinary proteins were kindly
provided by C. Serafini, Istituto di Ricerca Cesare Serono (Rome).
Construction of Probes and Screening of LibrariesEndotoxin concentration was below 10 pg/ml in the various culture
Total RNA from Jurkat cells was reverse-transcribed with Super-media.
Script RNase H2 reverse transcriptase (GIBCO-BRL) and random
primers (Promega, Madison WI). The resulting cDNA was amplifiedPurification of the Urinary IL-18-Binding Protein
by PCR (30 cycles of annealing at 558C, 2 min, and extension atRecombinant huIL-18 (2.5 mg) was coupled to 0.5 ml Affigel-10
708C, 1 min) using Taq DNA polymerase and primers corresponding(BioRad, Richmond, CA). Crude urinary proteins (500 ml of a 1000-
to TIGR clone THC123801 nucleotides 24±44 (sense) and 500±481fold concentrate) were passed on the IL-18 column. The column
(reverse). The PCR products were cloned into pGEM-Teasy TA clon-was washed with 250 ml phosphate-buffered 0.65 M NaCl (pH 7.4).
ing vector (Promega). DNA from individual clones was sequencedBound proteins were then eluted in 1 ml fractions with 25 mM citric
with T7 and SP6 primers.acid (pH 2.2) and benzamidine (1 mM) and immediately neutralized.
The resulting 477 bp fragment was 32P-labeled by random primingThe fractions were analyzed by SDS PAGE under nonreducing con-
and used for screening the following human cDNA libraries: a humanditions and silver staining.
monocyte cDNA library, constructed in lpCEV9 cloning vector (Gut-
kind et al., 1991), kindly provided by T. Miki; a human Jurkat leukemic
Immunization, RIA, and Immunoblotting T cell cDNA library; a human peripheral blood leukocyte cDNA li-
A rabbit was injected subcutaneously with affinity-purified urinary brary, and a human spleen cDNA library, all from Clontech (Palo
IL-18BP (z5 mg) in complete Freund's adjuvant and then boosted Alto, CA). A mouse spleen l Zap II cDNA library and a human pla-
six times with IL-18BP (z5 mg per boost). Urinary IL-18BP (2.5 mg) centa genomic library in l FIX II vector were from Stratagene (La
was labeled with 125I by the chloramine T procedure to 106 cpm/mg. Jolla, CA). Plasmids were excised from the lpCEV9 clones and self-
An antibody binding titer of 1:1000 was obtained as determined by ligated. cDNA clones from other libraries were isolated according
immunoprecipitation of 125I-IL-18BP with protein G beads (data not to the manufacturer's instructions. Standard protocols were used
shown). RIA of IL-18BP and immunological cross-reactivity were for these cloning procedures (Sambrook et al., 1989). Automated
similarly done by competition with 125I-IL-18BP using protein G DNA sequence analysis was performed on the isolated clones.
beads for immunoprecipitation. Immunoblotting was done with anti-
serum to IL-18BP (1:200) on preparations containing IL-18BP that RNA Blotting
were resolved by SDS-PAGE (10% acrylamide) under nonreducing Poly(A1) RNA was isolated from the total mouse spleen RNA by the
conditions. Immunoblotting of IL-18BP was done under nonreducing PolyATract kit (Promega). Poly(A1) RNA (1-2 mg) was resolved by
conditions, using 125I-protein A and autoradiography. agarose (1.5%) gel electrophoresis in MOPS-formaldehyde, trans-
ferred to a nylon membrane (Hybond N, Amersham) in 103 SSC,
Cross-Linking of Radiolabeled IL-18 to IL-18BP and baked (808C, 2 hr in vacuum). Membranes were probed with
IL-18BP (40 ml from eluted fractions of the affinity purification step) [32P]-dCTP-labeled DNA probes, washed, and autoradiographed
and 125I-IL-18 (5 3 106 cpm, 7 3 106 cpm/mg) were cross-linked (Sambrook et al., 1989). A membrane containing resolved human
with disuccinimidyl suberate (Pierce, Rockford, IL) as previously Poly(A1) RNA of different tissues (Human MTN Blot II, Clontech)
described (Novick et al., 1994). Products were analyzed by SDS- was similarly probed according to the manufacturer's instructions.
PAGE (7.5% acrylamide) under reducing conditions (25 mM DTT)
followed by autoradiography. Expression of IL-18BP-His6 in COS7 Cells
The coding region of the human IL-18BPa cDNA was amplified by
PCR with the sense primer 59TATATCTAGAGCCACCATGAGACACAAssay of IL-18 and Its Blocking by IL-18BP In Vitro
IL-18BP activity was determined by its ability to block the production ACTGGACACCA and the reverse primer 59ATATCTAGATTAATGATG
ATGATGATGATGACCCTGCTGCTGTGGACTGC.of IFNg and IL-8 in the following systems.
Murine splenocytes The reverse primer includes a cassette coding for a C-terminal
His6 tag. The resulting PCR product was cut with XbaI and clonedFreshly isolated splenocytes of C57Bl6 mice in RPMI-10% fetal
bovine serum (RPMI-10, 2.5 3 106 cells/ml) were stimulated (24 hr, into the XbaI site of the pEF-BOS expression vector (Mizushima and
Nagata, 1990), kindly provided by S. Nagata, to yield pEF-BOS-IL-378C) with preformed mixtures (20 min) of LPS (1 mg/ml), IL-18 (10
ng/ml), and the indicated amounts of IL-18BP in RPMI-10. Clarified 18BPa.
Batches of 6 3 107 COS7 cells suspended in 1.4 ml TD buffer,supernatants of 33 frozen cultures were assayed for muIFNg by a
sandwich-type ELISA (Fantuzzi et al., 1998). containing plasmid pEF-BOS-IL-18BPa (10 mg) and DEAE-dextran
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(1.2 mg), were incubated for 30 min at room temperature (Sompayrac Bailly, S., Ferrua, B., Fay, M., and Gougerot-Pocidalo, M.-A. (1990).
Paraformaldehyde fixation of LPS-stimulated human monocytes:and Danna, 1981). The cells were washed with DMEM-10% FBS,
technical parameters permitting the study of membrane IL-1 activity.plated for 4 hr, washed, and incubated 3 days in a serum-free DMEM.
Eur. Cytokine Net. 1, 47±51.Culture medium was concentrated 15-fold by ultrafiltration (10 kDa
cutoff), and the IL-18BPa-His6 was isolated on a Talon column (Clon- Bazan, J.F., Timans, J.C., and Kaselein, R.A. (1996). A newly defined
tech) according to the manufacturer's instructions. interleukin-1? Nature 379, 591.
Born, T.L., Thomassen, E., Bird, T.A., and Sims, J.E. (1998). Cloning
Electrophoretic Mobility Shift Assays of a novel receptor subunit, AcPL, required for interleukin-18 signal-
KG-1 cells (4 3 106 in 1 ml RPMI) were stimulated (20 min, 378C) ing. J. Biol. Chem. 273, 29445±29450.
with either huIL-18 (10 ng/ml) or huIL-18 premixed with IL-18BP.
Brauer, A.W., Oman, C.L., and Margolies, M.N. (1983). Use ofThe cells were then washed 33 with ice-cold phosphate-buffered
o-phtalaldehyde to reduce background during automated edmansaline (PBS) and immediately frozen in liquid nitrogen. The pellets
degradation. Anal. Biochem. 137, 134±142.
were resuspended in 33 the packed cell volume of buffer A (20 mM
Croston, G.E., Cao, Z., and Goeddel, D.V. (1995). NFkB activationTris [pH 7.6], 0.4 M NaCl, 0.2 mM EDTA, 20% glycerol, 1.5 mM
by interleukin-1 requires an IL-1 receptor-associated protein kinaseMgCl2, 2 mM DTT, 0.4 mM PMSF, 1 mM Na3VO4, and 2 mg/ml each
activity. J. Biol. Chem. 270, 16514±16517.of leupeptin, pepstatin, and aprotinin). Aliquots of the clarified
DiDonato, J.A., Hayakawa, M., Rothwarf, D.M., Zandi, E., and Karin,(15,000 3 g, 15 min) extracts (10 mg protein) were incubated (15
M. (1997). A cytokine-responsive IkB kinase that activates the tran-min, room temperature) with a [32P]gATP-labeled probe (3 3 104
scription factor NF-kB. Nature 388, 548±554.cpm), corresponding to the NF-kB binding element (Promega), to-
gether with poly dI.dC (500 ng, Pharmacia, Uppsala, Sweden) and Elson, G.C.A., Graber, P., Losberger, C., Herren, S., Gretener, D.,
denatured salmon sperm DNA (100 ng, Sigma) in 20 ml HEPES buffer Menoud, L.N., Wells, T.N.C., Kosco-Vilbois, M.H., and Gauchat, J.-F.
(pH 7.5, 10 mM), 60 mM KCl, 1 mM MgCl2, 2 mM EDTA, 1 mM (1998). Cytokine-like factor-1, a novel soluble protein, shares homol-
DTT, and 5% glycerol. The mixtures were then loaded onto 5% ogy with members of the cytokine type I receptor family. J. Immunol.
nondenaturing polyacrylamide gels and electrophoresed at 185 V 161, 1371±1379.
in 0.53 TBE (40 mM Tris HCl, 45 mM boric acid, and 2.5 mM EDTA), Engelmann, H., Aderka, D., Rubinstein, M., Rotman, D., and Wallach,
vacuum dried, and autoradiographed. D. (1989). A tumor necrosis factor-binding protein purified to homo-
geneity from human urine protects cells from tumor necrosis factor
Inhibition of LPS-Induced Responses in Mice by IL-18BP toxicity. J. Biol. Chem. 264, 11974±11980.
Four groups of three C57Bl6 female mice were injected intraperito- Engelmann, H., Novick, D., and Wallach, D. (1990). Two tumor necro-
neally with LPS (100 mg/mouse), LPS plus COS7-expressed human sis factor-binding proteins purified from human urine. Evidence for
IL-18BP (300 mg/mouse), IL-18BP alone, or PBS. Mice were bled 6 immunological cross-reactivity with cell surface tumor necrosis fac-
hr after injection, and the level of serum IFNg was determined by tor receptors. J. Biol. Chem. 265, 1531±1536.
ELISA. Splenocytes of these mice were obtained at 6 hr, cultured
Fantuzzi, G., Puren, A.J., Harding, M.W., Livingston, D.J., and Dinar-for 24 hr in media without additional stimulants, and IFNg production
ello, C.A. (1998). IL-18 regulation of IFN-g production and cell prolif-was then determined. Total RNA was isolated from the remaining
eration as revealed in interleukin-1b converting enzyme-deficientsplenocytes and subjected to RNA blotting with probes correspond-
mice. Blood 91, 2118±2125.ing to murine IFNg and actin.
Ghayur, T., Banerjee, S., Hugunin, M., Butler, D., Herzog, L., Carter,
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